Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Citrullination of linear and cyclic altered peptide ligands from myelin basic protein (MBP(87-99)) epitope elicits a Th1 polarized response by T cells isolated from multiple sclerosis patients: implications in triggering disease.
Deraos G, Chatzantoni K, Matsoukas MT, Tselios T, Deraos S, Katsara M, Papathanasopoulos P, Vynios D, Apostolopoulos V, Mouzaki A, Matsoukas J. Deraos G, et al. Among authors: mouzaki a. J Med Chem. 2008 Dec 25;51(24):7834-42. doi: 10.1021/jm800891n. J Med Chem. 2008. PMID: 19053745
Leptin and its soluble receptor in plasma of patients suffering from remitting-relapsing multiple sclerosis (MS) In vitro effects of leptin on type-1 and type-2 cytokine secretion by peripheral blood mononuclear cells, T-cells and monocytes of MS patients.
Chatzantoni K, Papathanassopoulos P, Gourzoulidou E, Mouzaki A. Chatzantoni K, et al. Among authors: mouzaki a. J Autoimmun. 2004 Sep;23(2):169-77. doi: 10.1016/j.jaut.2004.05.007. J Autoimmun. 2004. PMID: 15324935
Design and synthesis of a novel potent myelin basic protein epitope 87-99 cyclic analogue: enhanced stability and biological properties of mimics render them a potentially new class of immunomodulators.
Matsoukas J, Apostolopoulos V, Kalbacher H, Papini AM, Tselios T, Chatzantoni K, Biagioli T, Lolli F, Deraos S, Papathanassopoulos P, Troganis A, Mantzourani E, Mavromoustakos T, Mouzaki A. Matsoukas J, et al. Among authors: mouzaki a. J Med Chem. 2005 Mar 10;48(5):1470-80. doi: 10.1021/jm040849g. J Med Chem. 2005. PMID: 15743189
Anti-TNF-alpha antibody therapies in autoimmune diseases.
Chatzantoni K, Mouzaki A. Chatzantoni K, et al. Among authors: mouzaki a. Curr Top Med Chem. 2006;6(16):1707-14. doi: 10.2174/156802606778194217. Curr Top Med Chem. 2006. PMID: 17017952 Review.
Immunosuppressive drugs in HIV disease.
Argyropoulos C, Mouzaki A. Argyropoulos C, et al. Among authors: mouzaki a. Curr Top Med Chem. 2006;6(16):1769-89. doi: 10.2174/156802606778194271. Curr Top Med Chem. 2006. PMID: 17017956 Review.
149 results